ReviewJournal of clinical medicine2020
The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia.
Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.European journal of ophthalmology · 2024Guideline
- Longitudinal safety and efficacy of dual treatment with orthokeratology lenses and 0.01% atropine eye drops: a focus on epithelial changes and tear film stability.BMC ophthalmology · 2025Trial
- Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.BMC ophthalmology · 2022Trial
- Myopia Management Consensus Statement in South Korean Children 2025 by the Korean Myopia Society for the Korean Association for Pediatric Ophthalmology and Strabismus.Korean journal of ophthalmology : KJO · 2026Review
- Age and initial spherical equivalent influence the axial length elongation in children aged 9-17 years undergoing orthokeratology therapy.BMC ophthalmology · 2025Article
- Inhibition of lens-induced myopia in guinea pigs using a far-induced infrared ray material.Frontiers in medicine · 2025Article
- Analysis of factors influencing axial length changes in adolescents wearing corneal reshaping lenses.Arquivos brasileiros de oftalmologia · 2025Article
- Myopia Control: Are We Ready for an Evidence Based Approach?Ophthalmology and therapy · 2024Review
- Retardation of myopia by atropine regimes.International journal of ophthalmology · 2024Review
- Two Cases of Bilateral Rhegmatogenous Retinal Detachment During Orthokeratology Treatment.Cureus · 2023Article
- Peripheral Defocus and Myopia Management: A Mini-Review.Korean journal of ophthalmology : KJO · 2023Review
- High myopia control is comparable between multifocal rigid gas-permeable lenses and spectacles.Frontiers in medicine · 2023Article
- Effect of atropine 0.01% on myopia control in children aged 6-13 years during the 2022 lockdown in Shanghai.Frontiers in public health · 2023Article
- 0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial.International journal of ophthalmology · 2023Article
- Efficacy of the DRL orthokeratology lens in slowing axial elongation in French children.Frontiers in medicine · 2023Article
- Low-Concentration Atropine Monotherapy vs. Combined with MiSight 1 Day Contact Lenses for Myopia Management.Vision (Basel, Switzerland) · 2022Article
- Axial length shortening after orthokeratology and its relationship with myopic control.BMC ophthalmology · 2022Article
- Comparative Study of Relative Peripheral Refraction in Children With Different Degrees of Myopia.Frontiers in medicine · 2022Article
- Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.European journal of ophthalmology · 2021Article
- Corneal Penetration of Low-Dose Atropine Eye Drops.Journal of clinical medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric myopia has become a major international public health concern. The prevalence of myopia has undergone a significant increase worldwide. The purpose of this review of the current literature was to evaluate the peer-reviewed scientific literature on the efficacy and safety of low-dose atropine treatment combined with overnight orthokeratology for myopia control. A search was conducted in Pubmed and Web of Science with the following search strategy: (atropine OR low-dose atropine OR 0.01% atropine) AND (orthokeratology OR ortho-k) AND (myopia control OR myopia progression). All included studies improved myopia control by the synergistic effect of orthokeratology with low-dose atropine, compared with orthokeratology treatment alone. All studies included a short or medium follow-up period; therefore longer-term studies are necessary to validate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.